Renata Limited manufactures, markets, distributes, and exports human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, and other products. The company also offers lipid lowering, antiulcer, anti-parasitic and anti-protozoal, anti-fungal, anti-tuberculosis, and gastroprokinetic agents; and vitamins and minerals, and amino acid supplements. Its animal health products comprise antibiotic, cephalosporin, sulphonamides, anthelmintic, antiprotozoal, anti-histaminic, NSAID, glucocorticoid, appetizer and rumenotoric, and metabolic products, as well as vitamin-mineral injections; and anthelmintic, anti-coccidial, electrolyte, nutritional premix, and nutrition products, as well as poultry and aqua products, and live and killed vaccines. In addition, the company provides oncology-based products; agro-based products; poultry products; and consumer products. The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993. Renata Limited was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.